Your browser doesn't support javascript.
loading
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2.
Shi, Rui; Shan, Chao; Duan, Xiaomin; Chen, Zhihai; Liu, Peipei; Song, Jinwen; Song, Tao; Bi, Xiaoshan; Han, Chao; Wu, Lianao; Gao, Ge; Hu, Xue; Zhang, Yanan; Tong, Zhou; Huang, Weijin; Liu, William Jun; Wu, Guizhen; Zhang, Bo; Wang, Lan; Qi, Jianxun; Feng, Hui; Wang, Fu-Sheng; Wang, Qihui; Gao, George Fu; Yuan, Zhiming; Yan, Jinghua.
Afiliación
  • Shi R; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Shan C; University of Chinese Academy of Sciences, Beijing, China.
  • Duan X; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Chen Z; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Liu P; University of Chinese Academy of Sciences, Beijing, China.
  • Song J; Center of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Song T; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Bi X; Treatment and Research Center for Infectious Diseases, The Fifth Medical Center of PLA General Hospital, National Clinical Research Center for Infectious Diseases, Beijing, China.
  • Han C; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Wu L; Shanxi Academy of Advanced Research and Innovation, Taiyuan, China.
  • Gao G; College of Animal Science and Technology, Hebei Normal University of Science and Technology, Qinhuangdao, China.
  • Hu X; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zhang Y; Institute of Physical Science and Information, Anhui University, Hefei, China.
  • Tong Z; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Huang W; University of Chinese Academy of Sciences, Beijing, China.
  • Liu WJ; Institute of Physical Science and Information, Anhui University, Hefei, China.
  • Wu G; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Zhang B; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Wang L; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Qi J; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
  • Feng H; CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Wang FS; CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
  • Wang Q; Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institutes for Food and Drug Control, Beijing, China.
  • Gao GF; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yuan Z; NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
  • Yan J; Center for Biosafety Mega-Science, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan, China.
Nature ; 584(7819): 120-124, 2020 08.
Article en En | MEDLINE | ID: mdl-32454512

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / Betacoronavirus / Anticuerpos Antivirales Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Anticuerpos Neutralizantes / Glicoproteína de la Espiga del Coronavirus / Betacoronavirus / Anticuerpos Antivirales Límite: Animals / Female / Humans / Male Idioma: En Año: 2020 Tipo del documento: Article